BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35666530)

  • 21. Head-to-Head Comparison of DH3 HPV Test and HC2 Assay for Detection of High-Risk HPV Infection in Residual Cytology Samples from Cervical Cancer Screening Setting: Baseline and 3-Year Longitudinal Data.
    Fu Y; Li X; Li Y; Lu W; Xie X; Wang X
    Microbiol Spectr; 2022 Feb; 10(1):e0157021. PubMed ID: 35171029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of the TypeSeq Assay for Detection of 51 Human Papillomavirus Genotypes by Next-Generation Sequencing.
    Wagner S; Roberson D; Boland J; Yeager M; Cullen M; Mirabello L; Dunn ST; Walker J; Zuna R; Schiffman M; Wentzensen N
    J Clin Microbiol; 2019 May; 57(5):. PubMed ID: 30814267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A study of genotyping for management of human papillomavirus-positive, cytology-negative cervical screening results.
    Schiffman M; Burk RD; Boyle S; Raine-Bennett T; Katki HA; Gage JC; Wentzensen N; Kornegay JR; Aldrich C; Tam T; Erlich H; Apple R; Befano B; Castle PE
    J Clin Microbiol; 2015 Jan; 53(1):52-9. PubMed ID: 25339396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of loop-mediated isothermal amplification assay for detection and typing of human papilloma virus 16 and 18 from endocervical samples.
    Mudhigeti N; Kalawat U; Hulikal N; Kante M
    Indian J Med Microbiol; 2019; 37(2):241-247. PubMed ID: 31745026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CIN2+ detection of the HPV DNA Array genotyping assay in comparison with the Cobas 4800 HPV test and cytology.
    Pesic A; Krings A; Hempel M; Preyer R; Chatzistamatiou K; Agorastos T; Kaufmann AM
    Virol J; 2019 Jul; 16(1):92. PubMed ID: 31337408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical performance of the HPV-Risk assay on cervical samples in SurePath medium using the VALGENT-4 panel.
    Heideman DAM; Xu L; Hesselink AT; Doorn S; Ejegod DM; Pedersen H; Quint WGV; Bonde J; Arbyn M
    J Clin Virol; 2019 Dec; 121():104201. PubMed ID: 31629967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interest of human papillomavirus DNA quantification and genotyping in paired cervical and urine samples to detect cervical lesions.
    Ducancelle A; Legrand MC; Pivert A; Veillon P; Le Guillou-Guillemette H; De Brux MA; Beby-Defaux A; Agius G; Hantz S; Alain S; Catala L; Descamps P; Postec E; Caly H; Charles-Pétillon F; Labrousse F; Lunel F; Payan C
    Arch Gynecol Obstet; 2014 Aug; 290(2):299-308. PubMed ID: 24622934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effectiveness of HPV16 and HPV18 genotyping and cytology with different thresholds for the triage of human papillomavirus-based screening on self-collected samples.
    Song F; Du H; Wang C; Huang X; Wu R;
    PLoS One; 2020; 15(6):e0234518. PubMed ID: 32525936
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of clinical performances among Roche Cobas HPV, RFMP HPV PapilloTyper and Hybrid Capture 2 assays for detection of high-risk types of human papillomavirus.
    Yu S; Kwon MJ; Lee EH; Park H; Woo HY
    J Med Virol; 2015 Sep; 87(9):1587-93. PubMed ID: 25914215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Application of isothermal HPV DNA amplification test in cervical cancer screening].
    Wang L; Jiang MY; Qin Y; Li L; Wu ZN; Li TY; Wu T; Chen W
    Zhonghua Zhong Liu Za Zhi; 2018 Apr; 40(4):313-318. PubMed ID: 29730922
    [No Abstract]   [Full Text] [Related]  

  • 31. Assessment of a new low-cost, PCR-based strategy for high-risk human papillomavirus DNA detection for cervical cancer prevention.
    Surriabre P; Torrico A; Vargas T; Ugarte F; Rodriguez P; Fontaine V
    BMC Infect Dis; 2019 Oct; 19(1):842. PubMed ID: 31615443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The reliability of high-risk human papillomavirus detection by Aptima HPV assay in women with ASC-US cytology.
    Castle PE; Reid J; Dockter J; Getman D
    J Clin Virol; 2015 Aug; 69():52-5. PubMed ID: 26209379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HPV genotyping linear assay test comparison in cervical cancer patients: implications for HPV prevalence and molecular epidemiology in a limited-resource area in Bandung, Indonesia.
    Panigoro R; Susanto H; Novel SS; Hartini S; Sahiratmadja E
    Asian Pac J Cancer Prev; 2013; 14(10):5843-7. PubMed ID: 24289587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HPV genotype detection using hybrid capture sample preparation combined with whole genome amplification and multiplex detection with Luminex XMAP.
    Lowe B; Kobayashi L; Lorincz A; Mallonee R; O'Neil D; Thai H; Nazarenko I
    J Mol Diagn; 2010 Nov; 12(6):847-53. PubMed ID: 20847281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intra- and interlaboratory reproducibility evaluation toward international validation status of the AmpFire assay.
    Chung PYJ; Dhillon SK; Baraquin A; Tkachenka Y; Jacquot K; Prétet JL; Broeck DV; Arbyn M
    J Med Virol; 2024 Jun; 96(6):e29688. PubMed ID: 38847316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the AmpFire and MA-6000 polymerase chain reaction platforms for high-risk human papillomavirus testing in cervical precancer screening.
    Effah K; Agbemafle I; Essel NO; Amuah JE; Kotey EN; Antwi-Boasiako E; Kemawor S; Gedzah I; Tekpor E; Wormenor CM; Atuguba BH; Danyo S; Akakpo PK
    J Virol Methods; 2023 Jun; 316():114709. PubMed ID: 36924998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Performance of combined liquid based cytology and HPV nucleic acid test for detecting cervical precancer among women attending screening].
    Jiang MY; Feng RM; Wang L; Li TY; Zhang AA; Cui JF; Pan QJ; Zhang X; Liu ML; Gao F; Chen W; Qiao YL
    Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):750-756. PubMed ID: 30392339
    [No Abstract]   [Full Text] [Related]  

  • 38. An integrated isothermal nucleic acid amplification test to detect HPV16 and HPV18 DNA in resource-limited settings.
    Kundrod KA; Barra M; Wilkinson A; Smith CA; Natoli ME; Chang MM; Coole JB; Santhanaraj A; Lorenzoni C; Mavume C; Atif H; Montealegre JR; Scheurer ME; Castle PE; Schmeler KM; Richards-Kortum RR
    Sci Transl Med; 2023 Jun; 15(701):eabn4768. PubMed ID: 37343083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does full HPV genotyping perform similarly well in clinician-collected cervical samples and self-collected vaginal samples when using the CLART HPV4S assay?
    Solnæs JV; Njor SH; Tranberg M
    BMC Womens Health; 2023 Feb; 23(1):78. PubMed ID: 36823528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic Performance of HPV E6/E7 mRNA and HPV DNA Assays for the Detection and Screening of Oncogenic Human Papillomavirus Infection among Woman with Cervical Lesions in China.
    Wang HY; Lee D; Park S; Kim G; Kim S; Han L; Yubo R; Li Y; Park KH; Lee H
    Asian Pac J Cancer Prev; 2015; 16(17):7633-40. PubMed ID: 26625774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.